Edwards Lifesciences (EW) PT Raised to $125 at Jefferies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/16/2026
- Dow hits record high as oil slides; SpaceX soars
- Oil prices fall 4% to three-month low on hopes interim US-Iran deal will reopen Hormuz
- Robinhood cuts 10% of staff as CEO Tenev pushes for 'lean' team
- Buy this sector after recent pullback, Morgan Stanley urges investors
- No "big top" yet in risk assets, BofA says despite elevated sentiment
- Hut 8 Mining Corp. (HUT) PT Raised to $55 at KBW As Management Delivers
- Brixmor Property Group announces passing of former CEO James Taylor
- SpaceX to acquire Cursor in $60 billion all-stock deal
- Wall Street rallies, Dow ends with record on US-Iran deal, oil price slide
- Wolfe Research sees substantial upside to AMD estimates
Edwards Lifesciences Reports First Quarter Results
April 26, 2016 4:15 PM EDTIRVINE, Calif., April 26, 2016 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results for the quarter ended March 31, 2016.
First Quarter Highlights:
Sales grew 18.1% to $697.3 million, and underlying1 sales were up 19.7% THVT sales grew 37.0%, and underlying sales were up 38.3% GAAP EPS was $0.66, an increase of 17.9%, and adjusted2 EPS grew 24.6% to $0.71 2016 sales guidance raised to $2.7 - $3.0 billion from $2.6 - $2.85... More